Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lei, H. H.
Right arrow Articles by Coresh, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lei, H. H.
Right arrow Articles by Coresh, J.

Journal of the American Society of Nephrology, Vol 9, 1270-1276, Copyright © 1998 by American Society of Nephrology


REGULAR ARTICLES

Familial aggregation of renal disease in a population-based case- control study

HH Lei, TV Perneger, MJ Klag, PK Whelton and J Coresh
Department of Epidemiology, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland 21205-2223, USA.

Family history of renal disease has been associated with an increased risk of end-stage renal disease (ESRD). It is uncertain whether this risk is mediated by familial aggregation of risk factors for ESRD, such as diabetes and hypertension. The association of ESRD with familial aggregation of renal disease was examined in a large, population-based case-control study conducted in Maryland, Virginia, West Virginia, and Washington, DC. The number of first-degree relatives who were affected with any type of renal disease was compared between 689 newly treated ESRD patients registered in the Medicare ESRD program (92% of all eligible incident cases presenting between January and July of 1991) and 361 control subjects without ESRD who were selected by random-digit dialing (90% response rate). Patients and control subjects were frequency matched by age; patients with ESRD caused by polycystic kidney disease and other known hereditary kidney diseases were excluded. Analysis was conducted using multiple logistic regression. After controlling for the proband's age, gender, race, family size, socioeconomic status, and personal and family histories of diabetes and hypertension, having one first-degree relative with renal disease increased the odds of ESRD by 1.3 (95% confidence interval, 0.7 to 2.6) and having two or more affected first-degree relatives increased the odds of ESRD by 10.4 (95% confidence interval, 2.7 to 40.2). These data support familial aggregation of renal disease in excess of that predicted by clustering of diabetes and hypertension within families, suggesting that either genetic susceptibility or environmental exposures shared within families increase the risk of developing ESRD. This risk is also much higher when two or more first-degree relatives have renal disease. Unraveling the molecular basis of this increase in risk may provide new avenues for treatment and prevention of ESRD.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Lau, I. Sudbury, M. Thomson, P. L. Howard, A. B. Magil, and W. A. Cupples
Salt-resistant blood pressure and salt-sensitive renal autoregulation in chronic streptozotocin diabetes
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2009; 296(6): R1761 - R1770.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
B. I. Freedman, M. Bostrom, P. Daeihagh, and D. W. Bowden
Genetic Factors in Diabetic Nephropathy
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1306 - 1316.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. I. Freedman, D. W. Bowden, M. M. Sale, C. D. Langefeld, and S. S. Rich
Genetic Susceptibility Contributes to Renal and Cardiovascular Complications of Type 2 Diabetes Mellitus
Hypertension, July 1, 2006; 48(1): 8 - 13.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. I. Freedman, D. W. Bowden, S. S. Rich, C. J. Valis, M. M. Sale, P. J. Hicks, and C. D. Langefeld
A genome scan for all-cause end-stage renal disease in African Americans
Nephrol. Dial. Transplant., April 1, 2005; 20(4): 712 - 718.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. S. Fox, Q. Yang, L. A. Cupples, C.-Y. Guo, M. G. Larson, E. P. Leip, P. W.F. Wilson, and D. Levy
Genomewide Linkage Analysis to Serum Creatinine, GFR, and Creatinine Clearance in a Community-Based Population: The Framingham Heart Study
J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2457 - 2461.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. E. Ohmit, J. M. Flack, R. M. Peters, W. W. Brown, and R. Grimm
Longitudinal Study of the National Kidney Foundation's (NKF) Kidney Early Evaluation Program (KEEP)
J. Am. Soc. Nephrol., July 1, 2003; 14(90002): S117 - 121.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. I. Freedman
Susceptibility Genes for Hypertension and Renal Failure
J. Am. Soc. Nephrol., July 1, 2003; 14(90002): S192 - 194.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. C. Blantz
Reflections on the Past, Transitions to the Future: The American Society of Nephrology
J. Am. Soc. Nephrol., June 1, 2003; 14(6): 1695 - 1703.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
V. O. Shah, M. Scavini, C. A. Stidley, F. Tentori, T. K. Welty, J. W. MacCluer, A. S. Narva, A. Bobelu, C. P. Albert, D. S. Kessler, et al.
Epidemic of Diabetic and Nondiabetic Renal Disease among the Zuni Indians: The Zuni Kidney Project
J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1320 - 1329.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. Sommerer, M. Wiesel, J. Schweitzer-Rothers, E. Ritz, and M. Zeier
The living kidney donor: giving life, avoiding harm
Nephrol. Dial. Transplant., January 1, 2003; 18(1): 23 - 26.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Fava and A. T. Hattersley
The role of genetic susceptibility in diabetic nephropathy: evidence from family studies
Nephrol. Dial. Transplant., September 1, 2002; 17(9): 1543 - 1546.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. I. Freedman
End-stage renal failure in African Americans: insights in kidney disease susceptibility
Nephrol. Dial. Transplant., February 1, 2002; 17(2): 198 - 200.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP